Development of a nomogram predicting metastatic disease and the assessment of NCCN, AUA and EAU guideline recommendations for bone imaging in prostate cancer patients - Poll - MDSpire

Development of a nomogram predicting metastatic disease and the assessment of NCCN, AUA and EAU guideline recommendations for bone imaging in prostate cancer patients

  • By

  • Ming-Wei Ma

  • Xian-Shu Gao

  • Feng Lyu

  • Xiao-Bin Gu

  • Huan Yin

  • Hong-Zhen Li

  • Xiao-Ying Li

  • Xin Qi

  • Yun Bai

  • Jia-Yan Chen

  • July 20, 2020

  • 0 min

Share

Original Source(s)

Development of a nomogram predicting metastatic disease and the assessment of NCCN, AUA and EAU guideline recommendations for bone imaging in prostate cancer patients

  • by Ming-Wei Ma, Xian-Shu Gao, Feng Lyu, Xiao-Bin Gu, Huan Yin, Hong-Zhen Li, Xiao-Ying Li, Xin Qi, Yun Bai, Jia-Yan Chen

  • July 20, 2020

Related Content

Negative multiparametric magnetic resonance imaging for prostate cancer: further outcome and consequences

The combination of prostate health index and multiparametric magnetic resonance imaging in prostate cancer diagnosis: efficacy analysis in different PSA ranges and its clinical decision-guiding value

Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL?